ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer typically occurs in premenopausal women aged 40 to 55 years old and is defined by the absence of receptor estrogen (ER), progesterone (PR), and human epidermal growth factor receptor-2 (HER2) [1].